Use of a structured panel process to define quality metrics for antimicrobial stewardship programs

Infection Control and Hospital Epidemiology

Volumn 33, Issue 5, 2012, Pages 500-506

  Morris, Andrew M ^a,b   Brener, Stacey ^a,c   Dresser, Linda ^a,d   Daneman, Nick ^b,e,f   Dellit, Timothy H ^g   Avdic, Edina ^h   Bell, Chaim M ^c,d,f,i  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^g UNIVERSITY OF WASHINGTON   (United States)

^h JOHNS HOPKINS HOSPITAL   (United States)

ⁱ CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BLOODSTREAM INFECTION; COMMUNITY ACQUIRED PNEUMONIA; CONSENSUS; DRUG USE; HEALTH PROGRAM; HOSPITAL READMISSION; HUMAN; OUTCOME ASSESSMENT; SEPSIS; SKIN INFECTION; SOFT TISSUE INFECTION; TOTAL QUALITY MANAGEMENT;

ADVISORY COMMITTEES; ANTI-INFECTIVE AGENTS; CANADA; DELPHI TECHNIQUE; DRUG RESISTANCE, MICROBIAL; HEALTH CARE SURVEYS; HUMANS; QUALITY INDICATORS, HEALTH CARE; UNITED STATES;

EID: 84859364179     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/665324     Document Type: Article

References (37)

1. Roumie CL, Halasa NB, Grijalva CG, et al. Trends in antibiotic prescribing for adults in the United States-1995 to 2002. J Gen Intern Med 2005;20(8):697-702.
2. Dunagan WC, Woodward RS, Medoff G, et al. Antimicrobial misuse in patients with positive blood cultures. Am J Med 1989; 87(3):253-259.
3. Fridkin SK, Steward CD, Edwards JR, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999;29(2):245-252.
4. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001;33(6):757-762.
5. Pelletier LL Jr. Hospital usage of parenteral antimicrobial agents: a gradated utilization review and cost containment program. Infect Control 1985;6(6):226-230.
6. Polk R. Optimal use of modern antibiotics: emerging trends. Clin Infect Dis 1999;29(2):264-274.
7. Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302(21):2323-2329.
8. Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 2004;10(3):514-517.
9. de With K, Bergner J, Buhner R, et al. Antibiotic use in German university hospitals 1998-2000 (Project INTERUNI-II). Int J Antimicrob Agents 2004;24(3):213-218.
10. Goossens H, Ferech M, Vander SR, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a crossnational database study. Lancet 2005;365(9459):579-587.
11. Hsueh PR, Chen WH, Luh KT. Relationships between antimicrobial use and antimicrobial resistance in gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents 2005;26(6): 463-472.
12. Malhotra-Kumar S, Lammens C, Coenen S, Van HK, Goossens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 2007;369(9560):482-490.
13. Paterson DL. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 2004;38(suppl 4): S341-S345.
14. Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 2011;53(1):42-48.
15. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36(1): 53-59.
16. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006;42(suppl 2):S82-S89.
17. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005;41(3):327-333.
18. Lee NY, Lee HC, Ko NY, et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007;28(6):713-719.
19. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44(2): 159-177.
20. Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis 1988;157(5): 869-876.
21. Berrington A. Antimicrobial prescribing in hospitals: be careful what you measure. J Antimicrob Chemother 2010;65(1):163-168.
22. Curtis C, Marriott J, Langley C. Development of a prescribing indicator for objective quantification of antibiotic usage in secondary care. J Antimicrob Chemother 2004;54(2):529-533.
23. Filius PM, Liem TB, van der Linden PD, et al. An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother 2005;55(5):805-808.
24. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007;44(5):664-670.
25. Fink A, Kosecoff J, Chassin M, Brook RH. Consensus methods: characteristics and guidelines for use. Am J Public Health 1984; 74(9):979-983.
26. Brown N, Crawford I, Carley S, Mackway-Jones K. A Delphibased consensus study into planning for biological incidents. J Public Health (Oxf) 2006;28(3):238-241.
27. Guru V, Anderson GM, Fremes SE, O'Connor GT, Grover FL, Tu JV. The identification and development of Canadian coronary artery bypass graft surgery quality indicators. J Thorac Cardiovasc Surg 2005;130(5):1257.
28. Guttmann A, Razzaq A, Lindsay P, Zagorski B, Anderson GM. Development of measures of the quality of emergency department care for children using a structured panel process. Pediatrics 2006;118(1):114-123.
29. Handler SM, Hanlon JT, Perera S, et al. Consensus list of signals to detect potential adverse drug reactions in nursing homes. J Am Geriatr Soc 2008;56(5):808-815.
30. Lightfoot WS, Hefti A, Mariotti A. Using a Delphi panel to survey criteria for successful periodontal therapy in anterior teeth. J Periodontol 2005;76(9):1508-1512.
31. McGeer A, Campbell B, Emori TG, et al. Definitions of infection for surveillance in long-term care facilities. Am J Infect Control 1991;19(1):1-7.
32. Mertens AC, Cotter KL, Foster BM, et al. Improving health care for adult survivors of childhood cancer: recommendations from a delphi panel of health policy experts. Health Policy 2004;69(2): 169-178.
33. Syed AM, Hjarnoe L, Krumkamp R, Reintjes R, Aro AR. Developing policy options for SARS and SARS-like diseases-a Delphi study. Glob Public Health 2010;5(6):663-675.
34. Patel D, Lawson W, Guglielmo BJ. Antimicrobial stewardship programs: interventions and associated outcomes. Expert Rev Anti Infect Ther 2008;6(2):209-222.
35. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 2005;18(4):638-656.
36. Fishman N. Antimicrobial stewardship. Am J Infect Control 2006; 34(5 suppl 1):S55-S63.
37. Slama TG. Gram-negative antibiotic resistance: there is a price to pay. Crit Care 2008;12(suppl 4):S4.